Logo image
Persistence of K103N-Containing HIV-1 Variants after Single-Dose Nevirapine for Prevention of HIV-1 Mother-to-Child Transmission
Journal article   Open access   Peer reviewed

Persistence of K103N-Containing HIV-1 Variants after Single-Dose Nevirapine for Prevention of HIV-1 Mother-to-Child Transmission

Tamara S Flys, Deborah Donnell, Anthony Mwatha, Clemensia Nakabiito, Philippa Musoke, Francis Mmiro, J. Brooks Jackson, Laura A Guay and Susan H Eshleman
The Journal of infectious diseases, Vol.195(5), pp.711-715
03/01/2007
DOI: 10.1086/511433
PMID: 17262714
url
https://doi.org/10.1086/511433View
Published (Version of record) Open Access

Abstract

K103N-containing human immunodeficiency virus (HIV)-1 variants are selected in some women who receive single-dose (SD) nevirapine (NVP) for prevention of HIV-1 mother-infant transmission. We examined the persistence of K103N in women who received SD NVP prophylaxis. K103N was detected using the LigAmp assay (assay cutoff, 0.5% K103N). K103N was detected at 6-8 weeks in 60 (41.7%) of 144 women. Fading (lack of detection) of K103N was documented in 16 women by 2 years, 43 women by 3 years, and 55 women by 4 and 5 years. Slower fading was independently associated with HIV-1 subtype (D>A) and higher pre-NVP viral load.

Details

Metrics

Logo image